Tonabersat trial posts Phase 2 DME results to registry
The completed mid-stage study was sponsored by Jaeb Center for Health Research, NIH, NEI and the Juvenile Diabetes Research Foundation.

ClinicalTrials.gov posted results on Nov. 20 for NCT05727891, a completed Phase 2 trial evaluating Tonabersat in diabetic macular edema, the federal clinical-trial registry showed.
The update matters because Phase 2 trials are mid-stage human studies that usually examine safety, dosing and early signs of efficacy before larger confirmatory research.
Diabetic macular edema, or DME, is a diabetes-related eye condition involving fluid in the macula, the central part of the retina used for detailed vision. The registry record identifies Tonabersat as the intervention under evaluation for that condition.
The study was sponsored by Jaeb Center for Health Research, the National Institutes of Health, the National Eye Institute and the Juvenile Diabetes Research Foundation, according to ClinicalTrials.gov registry data.
The posting confirms that the trial is completed and that results have been added to the public registry. It does not, by itself, establish whether Tonabersat improves vision, retinal swelling or safety outcomes in DME patients.
The next evidence step is the content of the posted results and any peer-reviewed publication or regulatory filing that reports endpoints, adverse events and the enrolled patient population.
Source: ClinicalTrials.gov clinical registry, Nov. 20, 2026
Atlas360 reports health research and does not provide medical advice.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Wellness spending turns health into a rich status signal
- Moderna shares jump after cancer vaccine trial results land
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

